MAPK3 and liver failure: ActinGFP16 LOU were implanted 6 weeks before induction of liver failure through tamoxifen induction in the Fah−/− Fah−/−Rag2−/−Il2rg−/−Argflox/flox UBC‐Cre/ERT2 17.